Skip to main content
All lobbying filings

SUMMIT HEALTH CARE CONSULTING

SUMMIT HEALTH CARE CONSULTING filed a Q2 report for AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY on July 21, 2026, reporting $30,000 in lobbying income.

Lobbying for AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY · Health care trade association

All filings by SUMMIT HEALTH CARE CONSULTING · Everything AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 21, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
Illinois

Official filing document

 Lobbyists on this filing 1
  • CAMILLE BONTA
    Previously held: Legislative Correspondent, U.S. Senator John Glenn

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Support reform of the Medicare Access and CHIP Reauthorization Act, specifically reform of the Medicare Physician Fee Schedule (no specific legislation) Support the Improving Seniors Timely Access to Care Act (S. 1816, H.R. 3514) to codify CMS prior authorization regulations for MA plans and require greater transparency of prior authorization processes Support the Ensuring Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026 which reforms prior authorization processes and applies to Part D, CHIP, Medicaid. No specific legislation introduced in second quarter.

Oppose the Patients Deserve Price Tags Act (S. 2355), specifically Section 5. Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.

 Bills named in this filing 4
  • S. 1816
    Improving Seniors’ Timely Access to Care Act of 2025
  • H.R. 3514
    Improving Seniors’ Timely Access to Care Act of 2025
  • S. 2355
    Patients Deserve Price Tags Act
  • H.R. 9192
    Prior Authorization Reform for Autoimmune and Blood Disorders Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem